1. Home
  2. BBNX vs GSL Comparison

BBNX vs GSL Comparison

Compare BBNX & GSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • GSL
  • Stock Information
  • Founded
  • BBNX 2015
  • GSL 2007
  • Country
  • BBNX United States
  • GSL Greece
  • Employees
  • BBNX N/A
  • GSL N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • GSL Marine Transportation
  • Sector
  • BBNX Health Care
  • GSL Consumer Discretionary
  • Exchange
  • BBNX Nasdaq
  • GSL Nasdaq
  • Market Cap
  • BBNX 967.6M
  • GSL 1.0B
  • IPO Year
  • BBNX 2025
  • GSL 2006
  • Fundamental
  • Price
  • BBNX $27.09
  • GSL $34.30
  • Analyst Decision
  • BBNX Strong Buy
  • GSL Strong Buy
  • Analyst Count
  • BBNX 11
  • GSL 1
  • Target Price
  • BBNX $28.09
  • GSL $39.00
  • AVG Volume (30 Days)
  • BBNX 793.5K
  • GSL 380.5K
  • Earning Date
  • BBNX 10-28-2025
  • GSL 11-10-2025
  • Dividend Yield
  • BBNX N/A
  • GSL 7.24%
  • EPS Growth
  • BBNX N/A
  • GSL 23.53
  • EPS
  • BBNX N/A
  • GSL 11.07
  • Revenue
  • BBNX $88,570,000.00
  • GSL $747,044,000.00
  • Revenue This Year
  • BBNX $52.13
  • GSL $4.58
  • Revenue Next Year
  • BBNX $36.07
  • GSL N/A
  • P/E Ratio
  • BBNX N/A
  • GSL $3.12
  • Revenue Growth
  • BBNX 67.01
  • GSL 6.50
  • 52 Week Low
  • BBNX $8.89
  • GSL $17.73
  • 52 Week High
  • BBNX $30.47
  • GSL $34.84
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 58.70
  • GSL 72.36
  • Support Level
  • BBNX $24.33
  • GSL $30.68
  • Resistance Level
  • BBNX $29.22
  • GSL $34.84
  • Average True Range (ATR)
  • BBNX 2.06
  • GSL 0.95
  • MACD
  • BBNX 0.05
  • GSL 0.44
  • Stochastic Oscillator
  • BBNX 52.89
  • GSL 90.65

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About GSL Global Ship Lease Inc New

Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.

Share on Social Networks: